OneDigital Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

OneDigital Investment Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-510	Closed	-$203K	–	1464
2025 Q4	$203K	Sell	510 -220	-30%	-$97.4K	﹤0.01%	1444
2025 Q3	$333K	Sell	730 -387	-35%	-$158K	﹤0.01%	1124
2025 Q2	$364K	Sell	1,117 -94	-8%	-$26K	﹤0.01%	1049
2025 Q1	$327K	Buy	1,211 +165	+16%	+$42.4K	﹤0.01%	1056
2024 Q4	$246K	Buy	1,046 +25	+2%	+$6.58K	﹤0.01%	1230
2024 Q3	$281K	Buy	+1,021	New	+$266K	﹤0.01%	1189
2019 Q2	–	Sell	-800	Closed	-$75K	–	1195
2019 Q1	$75K	Hold	800	–	–	0.01%	418
2018 Q4	$58K	Buy	+800	New	+$61.5K	0.01%	430

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OneDigital Investment Advisors's ALNY Position: Q1 2026 in Review

OneDigital Investment Advisors sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 510 shares — an estimated $203K sold.

OneDigital Investment Advisors first reported a position in ALNY in Q4 2018 and held it in 8 quarters. The position peaked at $364K in Q2 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

OneDigital Investment Advisors reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
OneDigital Investment Advisors sold 510 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $203K.
OneDigital Investment Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2018 and held it in 8 quarters.
OneDigital Investment Advisors's Alnylam Pharmaceuticals position peaked at $364K in Q2 2025.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.